From: Chemo-informatics activity prediction, ligand based drug design, Molecular docking and pharmacokinetics studies of some series of 4, 6-diaryl-2-pyrimidinamine derivatives as anti-cancer agents
AATS2s
AATSC5s
MATS3e
SpMax8_Bhi
VIF
ME
1
7.247738
0.534996
0.57371
3.283985
− 0.00206
0.46022
− 0.01984
2.351116
− 0.05061
0.61146
0.037807
0.072472
3.271821
0.517679